ES2033077T3 - Medios de contraste que contienen radicales libres estables. - Google Patents

Medios de contraste que contienen radicales libres estables.

Info

Publication number
ES2033077T3
ES2033077T3 ES198989201880T ES89201880T ES2033077T3 ES 2033077 T3 ES2033077 T3 ES 2033077T3 ES 198989201880 T ES198989201880 T ES 198989201880T ES 89201880 T ES89201880 T ES 89201880T ES 2033077 T3 ES2033077 T3 ES 2033077T3
Authority
ES
Spain
Prior art keywords
media containing
contrast media
containing free
stable radicals
free stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989201880T
Other languages
English (en)
Inventor
Ib Leunbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amersham Health R&D AB
Original Assignee
Hafslund Nycomed Innovation AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Innovation AB filed Critical Hafslund Nycomed Innovation AB
Application granted granted Critical
Publication of ES2033077T3 publication Critical patent/ES2033077T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

SE DESCRIBE EL USO DE RADICALES LIBRES ESTABLES DEUTERADOS COMO AGENTES DE CONTRASTE PARA IMAGEN DE RESONANCIA MAGNETICA MEJORADA ESR.
ES198989201880T 1988-07-19 1989-07-17 Medios de contraste que contienen radicales libres estables. Expired - Lifetime ES2033077T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888817137A GB8817137D0 (en) 1988-07-19 1988-07-19 Compositions

Publications (1)

Publication Number Publication Date
ES2033077T3 true ES2033077T3 (es) 1993-03-01

Family

ID=10640699

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989201880T Expired - Lifetime ES2033077T3 (es) 1988-07-19 1989-07-17 Medios de contraste que contienen radicales libres estables.

Country Status (13)

Country Link
US (1) US5322065A (es)
EP (1) EP0351919B1 (es)
JP (1) JPH03506028A (es)
AT (1) ATE77755T1 (es)
AU (1) AU622692B2 (es)
DE (1) DE68901958T2 (es)
DK (1) DK8091D0 (es)
ES (1) ES2033077T3 (es)
GB (1) GB8817137D0 (es)
GR (1) GR3005234T3 (es)
PH (1) PH27247A (es)
WO (1) WO1990000904A1 (es)
ZA (1) ZA895468B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819753D0 (en) * 1988-08-19 1988-09-21 Nycomed As Apparatus
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
GB8929300D0 (en) * 1989-12-29 1990-02-28 Instrumentarium Corp Apparatus
GB9024528D0 (en) * 1990-11-12 1991-01-02 Instrumentarium Corp Improvements in and relating to magnetic resonance imaging
US5264204A (en) * 1992-04-30 1993-11-23 Mallinckrodt Medical, Inc. Hydrophilic free radicals for magnetic resonance imaging
DE4328639C2 (de) * 1993-08-23 2002-10-24 Lancaster Group Gmbh Verfahren zur Messung des antioxidativen Potentials der Haut
US5622687A (en) * 1994-11-15 1997-04-22 Molecular Biosystems, Inc. Calixarene conjugates useful as MRI and CT diagnostic imaging agents
WO1997024145A1 (fr) * 1995-12-28 1997-07-10 Daiichi Radioisotope Laboratories, Ltd. Medicaments d'aide au diagnostic
US5978694A (en) * 1997-02-27 1999-11-02 Uri Rapoport Method and apparatus for detecting a magnetically responsive substance
US6278893B1 (en) 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
US6185444B1 (en) * 1998-03-13 2001-02-06 Skelscan, Inc. Solid-state magnetic resonance imaging
US6503478B2 (en) 1999-01-13 2003-01-07 Lightouch Medical, Inc. Chemically specific imaging of tissue
US6574496B1 (en) * 1999-05-19 2003-06-03 Amersham Health As Magnetic resonance imaging
US7574248B2 (en) * 2002-05-17 2009-08-11 General Hospital Corporation Method and apparatus for quantitative bone matrix imaging by magnetic resonance imaging
KR20070063504A (ko) 2004-07-30 2007-06-19 지이 헬스케어 에이에스 조성물의 제조 방법, 조성물 및 그의 용도
US20070025918A1 (en) * 2005-07-28 2007-02-01 General Electric Company Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization
US8377419B2 (en) 2005-09-28 2013-02-19 The President And Fellows Of Harvard College Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging
WO2007064226A2 (en) 2005-12-01 2007-06-07 Ge Healthcare As Method of dynamic nuclear polarisation (dnp) using a trityl radical and a paramagnetic metal ion
EP1960001A2 (en) 2005-12-08 2008-08-27 Koninklijke Philips Electronics N.V. System and method for monitoring in vivo drug release using overhauser-enhanced nmr
US20080284429A1 (en) * 2005-12-10 2008-11-20 The President And Fellows Of Harvard College Situ Hyperpolarization of Imaging Agents
US20090252686A1 (en) * 2006-01-11 2009-10-08 President And Fellows Of Harvard College Ex Vivo Hyperpolarization of Imaging Agents
CN101506179B (zh) 2006-08-30 2012-08-22 通用电气医疗集团股份有限公司 动态核极化(dnp)的方法及用于所述方法的化合物和组合物
EP2902041A1 (en) 2007-12-19 2015-08-05 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
DE102008064400A1 (de) 2008-06-02 2009-12-03 Rohde & Schwarz Gmbh & Co. Kg Mikrowellenuntersuchung mit einem Kontrastmittel
US20100092390A1 (en) * 2008-10-09 2010-04-15 President And Fellows Of Harvard College Methods for Making Particles Having Long Spin-Lattice Relaxation Times
EP2476009A1 (en) 2009-09-10 2012-07-18 GE Healthcare UK Limited 13c-mr detection using hyperpolarised 13c-fructose
JP5758982B2 (ja) 2010-04-08 2015-08-05 ブラッコ・イメージング・ソシエタ・ペル・アチオニＢｒａｃｃｏ Ｉｍａｇｉｎｇ Ｓ．Ｐ．Ａ． 過分極基質の製造方法およびｍｒｉのための方法
WO2013053839A1 (en) 2011-10-12 2013-04-18 Bracco Imaging Spa Process for the preparation of hyperpolarized derivatives for use in mri analysis
US9693828B2 (en) 2011-12-05 2017-07-04 Bracco Imaging S.P.A. Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation in MRI analysis
US9925280B2 (en) 2012-04-02 2018-03-27 Bracco Imaging S.P.A. Hyperpolarized amino acids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2154857A5 (en) * 1971-09-28 1973-05-18 Commissariat Energie Atomique Deuterated nitroxide radical - tetra methyl 2,2,5,5-aza -1-cyclopentane oxa-3-oxyl-1
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4516075A (en) * 1983-01-04 1985-05-07 Wisconsin Alumni Research Foundation NMR scanner with motion zeugmatography
DE3328365A1 (de) * 1983-08-03 1985-02-21 Schering AG, 1000 Berlin und 4709 Bergkamen Neue diagnostische mittel
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
GB8522535D0 (en) * 1985-09-11 1985-10-16 Amersham Int Plc Contrast agent
US4834964A (en) * 1986-03-07 1989-05-30 M.R.I., Inc. Use of charged nitroxides as NMR image enhancing agents for CSF
US4719425A (en) * 1986-04-15 1988-01-12 Scientific Innovations, Inc. NMR imaging method and apparatus
JP2690987B2 (ja) * 1987-06-23 1997-12-17 ハフスルンド・ニユコメド・イノベイション・アクチェボラーグ 磁気共鳴像形成における改良
AU1966188A (en) * 1987-08-07 1989-03-09 Mallinckrodt, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5042488A (en) * 1987-09-29 1991-08-27 The Washington University Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ
US4893627A (en) * 1988-05-26 1990-01-16 The United States Of America As Represented By The United States Department Of Energy Method for nuclear magnetic resonance imaging using deuterum as a contrast agent

Also Published As

Publication number Publication date
DE68901958D1 (de) 1992-08-06
WO1990000904A1 (en) 1990-02-08
DE68901958T2 (de) 1992-12-10
PH27247A (en) 1993-05-03
DK8091A (da) 1991-01-17
JPH03506028A (ja) 1991-12-26
AU3867889A (en) 1990-02-19
GB8817137D0 (en) 1988-08-24
EP0351919A1 (en) 1990-01-24
ATE77755T1 (de) 1992-07-15
DK8091D0 (da) 1991-01-17
AU622692B2 (en) 1992-04-16
US5322065A (en) 1994-06-21
EP0351919B1 (en) 1992-07-01
GR3005234T3 (es) 1993-05-24
ZA895468B (en) 1990-04-25

Similar Documents

Publication Publication Date Title
ES2033077T3 (es) Medios de contraste que contienen radicales libres estables.
DE69130108D1 (de) Abbildung mittels magnetischer Resonanz
DE69010700D1 (de) Messung magnetischer Felder.
AR246956A1 (es) Compuesto quelante, un intermediario para preparar el mismo, y un procedimiento para preparar una composicion de medio de contraste.
ATE79622T1 (de) 1,4-diazepine.
SE9004060D0 (sv) Bensazepin- och bensotiazepin-derivat
AR246509A1 (es) Una cetimina, su preparacion y un agente de entrecruzamiento que la contiene.
ATE135540T1 (de) Lösbare riegelvorrichtung für auszugsführung
DK429089D0 (da) Alkylbenzylaminer
DE69317943D1 (de) Diagnostik-Anlage mittels magnetischer Kernresonanz
FR2356761A1 (fr) Melanges d'azureurs optiques et leur application
ITMI910802V0 (it) Insieme di tefton monouso con ago per endovena
KR900021048U (ko) 디에이티용 카세트 하우징
KR900012397U (ko) 전자식 다이어프램 펌프용 마그네트홀더
ATE96435T1 (de) Oxiran-phenylester und diese enthaltende fungizide.
DE69126549D1 (de) Nichtmagnetischer Einkomponententwickler
IT210455Z2 (it) Dispositivo di fisaggio di un gruppo ottico alla scocca di un autove icolo
ATE78463T1 (de) Schwefelhaltige acrylsaeureester und diese enthaltende fungizide.
DE58909089D1 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel.
KR950003084U (ko) 바늘의 수납처리가 용이한 주사기
BE873275A (fr) Melanges d'azureurs optiques
JO1561B1 (en) The use of optical conductors for measuring tween
ATE138541T1 (de) Parfumprobe
KR930018186U (ko) 투포원연사기의스핀들용자석고정구
IT8652974V0 (it) Visore di stereogrammi costituiti di diapositive intelaiate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351919

Country of ref document: ES